Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4+ T‐cell‐independent CD8+ T‐cell‐mediated tumor control
Open Access
- 2 October 2009
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 39 (10) , 2725-2736
Abstract
Antigen‐specific immunotherapy is an attractive strategy for cancer control. In the context of antiviral vaccines, adenoviral vectors have emerged as a favorable means for immunization. Therefore, we chose a strategy combining use of these vectors with another successful approach, namely linkage of the vaccine antigen to invariant chain (Ii). To evaluate this strategy we used a mouse model, in which an immunodominant epitope (GP33) of the LCMV glycoprotein (GP) represents the tumor‐associated neoantigen. Prophylactic vaccination of C57BL/6 mice with a replication‐deficient human adenovirus 5 vector encoding GP linked to Ii (Ad‐Ii‐GP) resulted in complete protection against GP33‐expressing B16.F10 tumors. Therapeutic vaccination with Ad‐Ii‐GP delayed tumor growth by more than 2 wk compared with sham vaccination. Notably, therapeutic vaccination with the linked vaccine was significantly better than vaccination with adenovirus expressing GP alone (Ad‐GP), or GP and Ii unlinked (Ad‐GP+Ii). Ad‐Ii‐GP‐ induced tumor control depended on an improved generation of the tumor‐associated neoantigen‐specific CD8+ T‐cell response and was independent of CD4+ T cells. IFN‐γ was shown to be a key player during the tumor degradation. Finally, Ad‐Ii‐GP but not Ad‐GP vaccination can break the immunological non‐reactivity in GP transgenic mice indicating that our vaccine strategy will prove efficient also against endogenous tumor antigens.Keywords
This publication has 35 references indexed in Scilit:
- Lymphocytic Choriomeningitis Virus Infection Yields Overlapping CD4 + and CD8 + T-Cell ResponsesJournal of Virology, 2008
- Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigensJournal of General Virology, 2007
- In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumorJournal of Experimental Medicine, 2007
- Lymphocyte-Mediated CytotoxicityAnnual Review of Immunology, 2002
- Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4+ T cell-dependent mechanismGene Therapy, 2001
- MHC class II presentation of endogenously expressed antigens by transfected dendritic cellsGene Therapy, 2001
- Immunopotentiating Role of IFN-γ in Early and Late Stages of Type 1 CD8 Effector Cell-Mediated Tumor RejectionClinical Immunology, 2001
- Duration of TCR Stimulation Determines Costimulatory Requirement of T CellsImmunity, 1996
- Molecular Mechanisms of Lymphocyte-Mediated Cytotoxicity and Their Role in Immunological Protection and Pathogenesis In VivoAnnual Review of Immunology, 1996
- Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune responseCell, 1991